[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-335881-105":59,"doc-detail-335881-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","exo1p53srebp1-axis-regulated-lipid-metabolism-promotes-prostate-cancer-progression","EXO1/P53/SREBP1 axis-regulated lipid metabolism promotes prostate cancer progression","","Prostate cancer (PCa) remains a major cause of male cancer mortality, while advanced disease still lacks effective therapies. Exonuclease 1 (EXO1), known for roles in mismatch repair and recombination, is identified as a novel PCa biomarker. EXO1 drives PCa progression by reprogramming lipid metabolism in prostate cancer cells, promoting intracellular lipid accumulation and disease advancement. Mechanistically, EXO1 increases SREBP1 expression by suppressing the P53 signaling pathway. Findings suggest EXO1 as a P53/SREBP1 axis target for diagnosis and treatment.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/exo1p53srebp1-axis-regulated-lipid-metabolism-promotes-prostate-cancer-progression/335881/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/exo1p53srebp1-axis-regulated-lipid-metabolism-promotes-prostate-cancer-progression/335881.png","ImageObject",300,407,{"name":92,"@type":93},"Logic","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-06","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What role does EXO1 play in prostate cancer progression?","Question",{"text":112,"@type":113},"EXO1 acts as a novel biomarker and promotes prostate cancer progression by regulating lipid metabolism reprogramming in prostate cancer cells.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How does EXO1 influence SREBP1 and P53 signaling?",{"text":117,"@type":113},"EXO1 promotes SREBP1 expression by inhibiting the P53 signaling pathway, linking the EXO1 effect to the P53/SREBP1 axis.",{"name":119,"@type":110,"acceptedAnswer":120},"What therapeutic implications do the findings suggest?",{"text":121,"@type":113},"The results indicate that EXO1-mediated lipid reprogramming through the P53/SREBP1 axis could provide new insights and potential therapeutic targets for PCa.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},335881,1790930482,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":4},1099513958762,"https://ap-avatar.wpscdn.com/avatar/1000023916a998db790?x-image-process=image/resize,m_fixed,w_180,h_180&k=1784791008015729253","Wang et al. Journal of Translational Medicine (2024) 22:104  \n[https://doi.org/10.1186/s12967-023-04822-z](https://doi.org/10.1186/s12967-023-04822-z)  \nJournal of Translational Medicine  \n RESEARCH Open Access  \nEXO1/P53/SREBP1 axis-regulated lipid metabolism promotes prostate cancer progression  \nZefeng Wang1†, Zheng Chao2†, Qi Wang3, Fan Zou1, Tianbao Song1, Lizhe Xu1, Jinzhuo Ning1* and Fan Cheng1*  \nAbstract  \nProstate cancer (PCa) is one of the most common malignant tumors affecting the male genitourinary system. However, there is currently a lack of effective treatments for patients with advanced prostate cancer, which significantly impacts men’s overall health. Exonuclease 1 (EXO1), a protein with mismatch repair and recombination functions, has been found to play a vital role in various diseases. In our study, we discovered that EXO1 acts as a novel biomarker of PCa, which promotes prostate cancer progression by regulating lipid metabolism reprogramming in prostate cancer cells. Mechanistically, EXO1 promotes the expression of SREBP1 by inhibiting the P53 signaling pathway. In summary, our findings suggest that EXO1 regulated intracellular lipid reprogramming through the P53/SREBP1 axis, thus promoting PCa progression. The result could potentially lead to new insights and therapeutic targets for diagnosing and treating PCa.  \nKeywords Prostate cancer, Lipid metabolism, EXO1, P53, Biomarker  \nIntroduction  \nProstate cancer (PCa) is a malignant genitourinary tumor and the second leading cause of cancer-related deaths in men globally. A previous study estimated that approximately 1.4 million new cases of PCa and 375,000 deaths occur annually worldwide [1]. Several risk factors contribute to PCa, including age, family history of tumors,  \n†Zefeng Wang and Zheng Chao have contributed equally to this work.  \n*Correspondence: Jinzhuo Ning [njz120511@whu.edu.cn](njz120511@whu.edu.cn)[ ](njz120511@whu.edu.cn)Fan Cheng [urology1969@aliyun.com](urology1969@aliyun.com)  \n1 Department of Urology, Renmin Hospital of Wuhan University, Wuhan 430060, China  \n2 Department of Urology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China  \n3 Department of Urology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China  \nlifestyle, environmental factors, and certain genetic mutations. Biochemical recurrence is observed in about one-third of patients following radical prostatectomy, anda significant number of these patients progress to desmoplasia-resistant [2]. The median survival of patients with desmoplasia PCa ranges from 9 to 30 months [3].  \nExonuclease 1(EXO1) is a gene that encodes a protein with an exonuclease, and the RNase H enzyme plays a key role in mismatch repair and double-strand break repair [4]. EXO1 has been linked to various diseases including Aicardi-Gouteres syndrome [5]. Alternative splicing of the EXO1 gene produces two isoforms in humans, EXO1a and EXO1b. Moreover a-48-amino-acid truncation of the C-terminal region of EXO1a impairsits DNA excision activity. Several studies have shown a strong association between EXO1 and the prognosis of malignant tumors [6, 7], including PCa [8]. However, the exact mechanism by which EXO1 promotes PCa progression remains unclear.  \n© The Author(s) 2024. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not p","cbCaipXYofF2WCPd","https://ap.wps.com/l/cbCaipXYofF2WCPd","pdf",21098594,18,"English","# Abstract\n# Keywords\n# Introduction\n## Prostate cancer burden and risk factors\n## EXO1 and DNA repair relevance\n## P53 signaling and lipid metabolism\n# Methods\n## Dataset\n# Results\n## EXO1 promotes proliferation, metastasis, and lipid accumulation","[{\"question\":\"What role does EXO1 play in prostate cancer progression?\",\"answer\":\"EXO1 acts as a novel biomarker and promotes prostate cancer progression by regulating lipid metabolism reprogramming in prostate cancer cells.\"},{\"question\":\"How does EXO1 influence SREBP1 and P53 signaling?\",\"answer\":\"EXO1 promotes SREBP1 expression by inhibiting the P53 signaling pathway, linking the EXO1 effect to the P53/SREBP1 axis.\"},{\"question\":\"What therapeutic implications do the findings suggest?\",\"answer\":\"The results indicate that EXO1-mediated lipid reprogramming through the P53/SREBP1 axis could provide new insights and potential therapeutic targets for PCa.\"}]","EXO1/P53/SREBP1 axis-regulated lipid metabolism promotes prostate cancer progression | PDF",1790012692,45]